ASX:BDA

Stock Analysis Report

Executive Summary

BOD Australia Limited operates as a developer, manufacturer, distributor, and marketer of plant-based medicinal cannabis, health and supplement products, and cosmetic solutions primarily in Australia.

Snowflake

Fundamentals

Flawless balance sheet with weak fundamentals.

Risks

  • Bod Australia has significant price volatility in the past 3 months.
  • Bod Australia is not covered by any analysts.

Share Price & News

How has Bod Australia's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-13.0%

ASX:BDA

7.8%

AU Retail Distributors

1.8%

AU Market


1 Year Return

-21.7%

ASX:BDA

-2.4%

AU Retail Distributors

2.2%

AU Market

BDA underperformed the Retail Distributors industry which returned -1.7% over the past year.

BDA underperformed the Market in Australia which returned 1.9% over the past year.


Share holder returns

BDAIndustryMarket
7 Day-13.0%7.8%1.8%
30 Day-16.1%3.2%-3.7%
90 Day77.4%11.9%1.1%
1 Year-21.7%-21.7%0.3%-2.4%8.0%2.2%
3 Yearn/a24.2%13.0%32.9%15.6%
5 Yearn/a115.9%65.8%39.3%8.4%

Price Volatility Vs. Market

How volatile is Bod Australia's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Bod Australia undervalued based on future cash flows and its price relative to the stock market?

5.11x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Bod Australia to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Bod Australia to establish if it is available at substantial discount.


Price Based on Earnings

Bod Australia is loss making, we can't compare its value to the AU Retail Distributors industry average.

Bod Australia is loss making, we can't compare the value of its earnings to the Australia market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Bod Australia, we can't assess if its growth is good value.


Price Based on Value of Assets

Bod Australia is overvalued based on assets compared to the AU Retail Distributors industry average.


Next Steps

Future Growth

How is Bod Australia expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

7.6%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bod Australia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Bod Australia performed over the past 5 years?

-54.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Bod Australia does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Bod Australia's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Bod Australia's 1-year growth to the AU Retail Distributors industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Bod Australia has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Bod Australia has efficiently used its assets last year compared to the AU Retail Distributors industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Bod Australia improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Bod Australia's financial position?


Financial Position Analysis

Bod Australia is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Bod Australia has no long term commitments.


Debt to Equity History and Analysis

Bod Australia has no debt.

Bod Australia currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

Low level of unsold assets.

Bod Australia has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Bod Australia has sufficient cash runway for 1.5 years based on current free cash flow.

Bod Australia has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 65.8% each year.


Next Steps

Dividend

What is Bod Australia's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Bod Australia's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Bod Australia's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Bod Australia has not reported any payouts.

Unable to verify if Bod Australia's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Bod Australia has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Bod Australia's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average board tenure


CEO

Jo Patterson 0

0.0yrs

Tenure

AU$294,280

Compensation

Ms. Joanne Patterson, also known as Jo, MBus. (Marketing), serves as Chief Executive Officer of Bod Australia Limited. Ms. Patterson founded Bod Australia in 2014. Ms. Patterson is a strategic marketer wit ...


CEO Compensation Analysis

Jo's remuneration is about average for companies of similar size in Australia.

Jo's compensation has been consistent with company performance over the past year, both up more than 20%.


Board Age and Tenure

2.0yrs

Average Tenure

53yo

Average Age

The average tenure for the Bod Australia board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyAU$520,00015 Aug 19
SG Hiscock & Company Ltd.
EntityCompany
Shares1,000,000
Max PriceAU$0.52
BuyAU$462,49923 Jul 19
Tribeca Investment Partners Pty Ltd.
EntityCompany
Shares1,250,000
Max PriceAU$0.37
SellAU$13,76024 May 19
IFM Investors Pty Ltd
EntityCompany
Shares50,000
Max PriceAU$0.28
BuyAU$399,47431 Mar 19
Tribeca Investment Partners Pty Ltd.
EntityCompany
Shares845,332
Max PriceAU$0.56
BuyAU$30,92011 Feb 19
IFM Investors Pty Ltd
EntityCompany
Shares64,877
Max PriceAU$0.48
BuyAU$50,00016 Jan 19
Joanne Patterson
EntityIndividual
Role
Chief Executive Officer
CEO, Director & Member of Medical Advisory Board
Shares100,000
Max PriceAU$0.50
BuyAU$9,90016 Jan 19
George Livery
EntityIndividual
Role
Chairman of the Board
Executive Chairman
Shares20,000
Max PriceAU$0.49
BuyAU$10,75016 Dec 18
Stephen Thompson
EntityIndividual
Role
Member of the Board of Directors
Executive Director
Shares25,000
Max PriceAU$0.43
BuyAU$402,21012 Nov 18
SG Hiscock & Company Ltd.
EntityCompany
Shares630,720
Max PriceAU$0.64
BuyAU$1,854,99715 Oct 18
Tribeca Investment Partners Pty Ltd.
EntityCompany
Shares3,500,000
Max PriceAU$0.53
BuyAU$1,854,99804 Oct 18
Tribeca Investment Partners Pty Ltd.
EntityCompany
Shares3,500,000
Max PriceAU$0.53

Ownership Breakdown


Management Team

  • Craig Weller

    COO & Member of Medical Advisory Board

    • Tenure: 2.0yrs
    • Compensation: AU$294.28k
  • George Livery (52yo)

    Executive Chairman

    • Tenure: 0.9yrs
  • Jo Patterson

    CEO, Director & Member of Medical Advisory Board

    • Tenure: 0.0yrs
    • Compensation: AU$294.28k
  • Adele Hosseini

    Chief Scientific Officer & Member of Medical Advisory Board

    • Tenure: 2.0yrs
  • Stephen Thompson

    Executive Director

    • Tenure: 0.9yrs
  • Stephen Kelly

    Company Secretary

    • Tenure: 0.9yrs

Board Members

  • Simon O'Loughlin (62yo)

    Non-Executive Director

    • Tenure: 3.0yrs
    • Compensation: AU$43.80k
  • Simon Taylor (53yo)

    Non-Executive Director

    • Tenure: 3.0yrs
    • Compensation: AU$38.33k
  • Craig Weller

    COO & Member of Medical Advisory Board

    • Tenure: 2.0yrs
    • Compensation: AU$294.28k
  • George Livery (52yo)

    Executive Chairman

    • Tenure: 0.9yrs
  • Jo Patterson

    CEO, Director & Member of Medical Advisory Board

    • Tenure: 0.0yrs
    • Compensation: AU$294.28k
  • Stella Valenzuela

    Member of Medical Advisory Board

    • Tenure: 2.0yrs
  • Adele Hosseini

    Chief Scientific Officer & Member of Medical Advisory Board

    • Tenure: 2.0yrs
  • Nick Burgess

    Member of Medical Advisory Board

    • Tenure: 2.0yrs
  • Stephen Thompson

    Executive Director

    • Tenure: 0.9yrs
  • Akash Bedi

    Non-Executive Director

    • Tenure: 0.1yrs

Company Information

Bod Australia Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bod Australia Limited
  • Ticker: BDA
  • Exchange: ASX
  • Founded:
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: AU$38.608m
  • Shares outstanding: 88.75m
  • Website: https://bodaustralia.com

Location

  • Bod Australia Limited
  • 377 New South Head Road
  • Level 1
  • Double Bay
  • New South Wales
  • 2028
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BDAASX (Australian Securities Exchange)YesOrdinary SharesAUAUDOct 2016
BDACHIA (Chi-X Australia)YesOrdinary SharesAUAUDOct 2016

Biography

BOD Australia Limited operates as a developer, manufacturer, distributor, and marketer of plant-based medicinal cannabis, health and supplement products, and cosmetic solutions primarily in Australia. Its  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/23 10:37
End of Day Share Price2019/08/23 00:00
Earnings2018/12/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.